Biological
vosoritide
vosoritide is a biological therapy with 6 clinical trials. Currently 5 active trials ongoing.
Total Trials
6
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Active Trials
5(83%)
Phase Distribution
Ph phase_3
2
33%
Ph phase_2
4
67%
Phase Distribution
0
Early Stage
4
Mid Stage
2
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
4(66.7%)
Phase 3Large-scale testing
2(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
5
trials recruiting
Total Trials
6
all time
Status Distribution
Active(6)
Detailed Status
Active, not recruiting3
Recruiting2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
5
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 24 (66.7%)
Phase 32 (33.3%)
Trials by Status
recruiting233%
enrolling_by_invitation117%
active_not_recruiting350%
Recent Activity
5 active trials
Showing 5 of 6
recruitingphase_2
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
NCT07126262
active_not_recruitingphase_2
Vosoritide for Selected Genetic Causes of Short Stature
NCT04219007
active_not_recruitingphase_2
A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia
NCT04554940
active_not_recruitingphase_3
Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia
NCT06455059
enrolling_by_invitationphase_3
Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia
NCT07073014
Clinical Trials (6)
Showing 6 of 6 trials
NCT07126262Phase 2
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
NCT04219007Phase 2
Vosoritide for Selected Genetic Causes of Short Stature
NCT04554940Phase 2
A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia
NCT06455059Phase 3
Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia
NCT07073014Phase 3
Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia
NCT05849389Phase 2
Vosoritide for Short Stature in Turner Syndrome
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6